Insight Molecular Diagnostics Inc. - Common Stock, no par value (IMDX)

Q: What does CUSIP 68235C206 represent in this 13F holders report?

CUSIP 68235C206 is the security identifier for IMDX - Insight Molecular Diagnostics Inc. - Common Stock, no par value used to aggregate holder disclosures.

Q: How many institutions held IMDX - Insight Molecular Diagnostics Inc. - Common Stock, no par value in Q2 2023?

1 institutional investor reported IMDX - Insight Molecular Diagnostics Inc. - Common Stock, no par value for Q2 2023. Use the holders table for investor-level position and value details.

CUSIP: 68235C206

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock, no par value
Shares outstanding: 32,330,312
Total 13F shares: 15,000
Share change: +15,000
Total reported value: $3,450
Price per share: $0.23
Number of holders: 1
Value change: +$3,450
Number of buys: 1

Quarterly Holders Quick Answers

What is CUSIP 68235C206?
CUSIP 68235C206 identifies IMDX - Insight Molecular Diagnostics Inc. - Common Stock, no par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023

Recent filing periods for CUSIP 68235C206:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of IMDX - Insight Molecular Diagnostics Inc. - Common Stock, no par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BROADWOOD CAPITAL INC	13F	Company	82%	23,353,697	$8,276,550	—	31 Mar 2023	13F
PURA VIDA INVESTMENTS, LLC	13F 3/4/5	Company · 10%+ Owner	50%	14,166,163	$5,020,488	—	31 Mar 2023	13F 3/4/5
AWM Investment Company, Inc.	13F	Company	24%	6,773,051	$2,400,369	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	15%	4,359,202	$1,544,901	—	31 Mar 2023	13F
Defender Capital, LLC.	13F	Company	8.3%	2,363,430	$837,600	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	5%	1,425,386	$505,157	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	3.5%	992,454	$351,725	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	1.7%	474,711	$168,000	—	31 Mar 2023	13F
John Peter Gutfreund	3/4/5	Former Director	— mixed-class rows	760,000 mixed-class rows	$153,654	—	30 Jun 2023	3/4/5
Ronald Asbury Andrews	3/4/5	Former CEO, Director	— mixed-class rows	633,212 mixed-class rows	$125,332	—	01 Dec 2022	3/4/5
Alfred D. Kingsley	3/4/5	Director	— mixed-class rows	597,878 mixed-class rows	$109,143	—	23 Jun 2023	3/4/5
STATE STREET CORP	13F	Company	0.99%	281,845	$99,886	—	31 Mar 2023	13F
Gisela Paulsen	3/4/5	Former President and COO	— class O/S missing	366,500	$78,761	—	16 Dec 2022	3/4/5
Li Yu	3/4/5	VP Cntrllr/Prncpl Acctng Offcr	— mixed-class rows	41,872 mixed-class rows	$76,536	—	18 May 2022	3/4/5
Penbrook Management LLC	13F	Company	0.73%	207,675	$73,600	—	31 Mar 2023	13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.72%	205,300	$72,758	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.68%	194,911	$69,077	—	31 Mar 2023	13F
LPL Financial LLC	13F	Company	0.52%	147,563	$52,296	—	31 Mar 2023	13F
Ross Douglas T.	3/4/5	Former CSO	— class O/S missing	234,114	$50,311	—	21 Dec 2022	3/4/5
Cavan M. Redmond	3/4/5	Director	— class O/S missing	120,863	$25,973	—	24 Jun 2022	3/4/5
Bank of New York Mellon Corp	13F	Company	0.22%	63,107	$22,365	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.22%	62,284	$22,073	—	31 Mar 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.21%	59,600	$21,000	—	31 Mar 2023	13F
Mitchell S. Levine	3/4/5	Chief Financial Officer	— mixed-class rows	174,580 mixed-class rows	$18,713	—	15 Mar 2022	3/4/5
AMERIPRISE FINANCIAL INC	13F	Company	0.15%	42,400	$15,027	—	31 Mar 2023	13F
WEALTH EFFECTS LLC	13F	Company	0.14%	40,500	$14,353	—	31 Mar 2023	13F
Tower Research Capital LLC (TRC)	13F	Company	0.13%	38,236	$14,000	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.13%	36,534	$12,948	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.12%	34,776	$12,325	—	31 Mar 2023	13F
DEUTSCHE BANK AG\	13F	Company	0.12%	33,890	$11,997	—	31 Mar 2023	13F
Merit Financial Group, LLC	13F	Company	0.11%	32,000	$11,341	—	31 Mar 2023	13F
LEE DANNER & BASS INC	13F	Company	0.1%	27,763	$10,000	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.09%	26,288	$9,306	—	31 Mar 2023	13F
JANE STREET GROUP, LLC	13F	Company	0.09%	24,806	$8,791	—	31 Mar 2023	13F
OSAIC HOLDINGS, INC.	13F	Company	0.09%	24,450	$8,664	—	31 Mar 2023	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.08%	21,500	$7,619	—	31 Mar 2023	13F
Westshore Wealth, LLC	13F	Company	0.07%	20,000	$7,088	—	31 Mar 2023	13F
UBS Group AG	13F	Company	0.07%	18,837	$6,668	—	31 Mar 2023	13F
Jennifer Levin Carter	3/4/5	Director	— mixed-class rows	75,500 mixed-class rows	$6,554	—	15 Aug 2022	3/4/5
Melinda Griffith	3/4/5	Director	— mixed-class rows	75,000 mixed-class rows	$6,447	—	15 Aug 2022	3/4/5
Williams Jones Wealth Management, LLC.	13F	Company	0.05%	15,000	$5,316	—	31 Mar 2023	13F
Raymond James Financial Services Advisors, Inc.	13F	Company	0.05%	14,776	$5,237	—	31 Mar 2023	13F
TWO SIGMA SECURITIES, LLC	13F	Company	0.04%	12,479	$4,423	—	31 Mar 2023	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.04%	11,830	$4,193	—	31 Mar 2023	13F
LEVIN CAPITAL STRATEGIES, L.P.	13F	Company	0.04%	10,500	$3,721	—	31 Mar 2023	13F
Freestone Capital Holdings, LLC	13F	Company	0.04%	10,000	$3,544	—	31 Mar 2023	13F
LMR Partners LLP	13F	Company	0.04%	10,000	$3,544	—	31 Mar 2023	13F
PNC FINANCIAL SERVICES GROUP, INC.	13F	Company	0.04%	10,000	$3,540	—	31 Mar 2023	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0.01%	4,164	$1,476	—	31 Mar 2023	13F
JPMORGAN CHASE & CO	13F	Company	0.01%	3,104	$1,000	—	31 Mar 2023	13F

Institutional Holders of Insight Molecular Diagnostics Inc. - Common Stock, no par value (IMDX) as of Q2 2023

As of 30 Jun 2023, Insight Molecular Diagnostics Inc. - Common Stock, no par value (IMDX) was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 15,000 shares. The largest 1 holders included Williams Jones Wealth Management, LLC.. This page lists 1 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q4 2025 Across Filers

Q4 2025 holders

Q2 2023 holders

Holder diff

-33

Investor	Q4 2025 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.